BioXcel Therapeutics
BTAI
1,83 €
Share price
3.65%
Change (1 day)
-95.64%
Change (1 year)
Categories
BioXcel Therapeutics (BTAI) - P/B ratio
P/B ratio as of April 2025 : -0.1275
According to BioXcel Therapeutics's latest financial reports the company has a price-to-book ratio of 4.79667.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
BioXcel Therapeutics - P/B ratio (from 2018 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | -0.2167 | -85.82% |
| 2023-12-31 | -1.53 | -119.49% |
| 2022-12-31 | 7.84 | 205.53% |
| 2021-12-31 | 2.57 | -52.98% |
| 2020-12-31 | 5.46 | -44.45% |
| 2019-12-31 | 9.83 | 531.99% |
| 2018-12-31 | 1.55 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 1.70 | -1,433.68% | 🇺🇸 USA |